OpenVSafe by OpenVAERS
Search V-safe

E7T-82848-72978

2 vaccinations 10 coded responses 24 check-ins 9 free-text entries 2 call cases
Sex
Female
Age at first dose
0-4
ZIP prefix
665 / KS
Registered
2022-06-24
Relationship
Child or adolescent in my care
Guardian
VLZ-70357-91439
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-23
    Dose 1 — Moderna
  2. 2022-06-24
    Registered in v-safe
  3. 2022-06-24
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Site: Pain · None
    Under 3 check-in
  4. 2022-06-25
    Survey response — days 1–6 daily, dose 1, under 3
    MedDRA: Rash, Rash erythematous — Feeling: Good
    Free text: mild red rash to inner thigh of leg with injection yesterday afternoon, but resolved by evening
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-06-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-06-27
    Survey response — days 1–6 daily, dose 1, under 3
    MedDRA: Body temperature increased, Irritability, Teething — Feeling: Good · Fever
    Free text: Only mentioning 99.6 temp bc she felt feverish and seemed fussy, but no true fever. Note appears to be teething with 2 year molars as well
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-06-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-06-30
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  10. 2022-07-07
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-07-14
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-07-21
    Health check-in — day 28, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-07-27
    Dose 2 — Moderna
  14. 2022-07-28
    Survey response — days 1–6 daily, dose 2, under 3
    MedDRA: Pain in extremity, Self-medication — Feeling: Good · Site: Pain
    Free text: Note leg pain was yesterday several hours after the shot, improved with ibuprofen. No complaints so far today
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-07-29
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  16. 2022-07-30
    Survey response — days 1–6 daily, dose 2, under 3
    MedDRA: Headache, Pallor, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Poor · Fever · Irritability/crying · Be unable to do your normal daily activities
    Free text: Fever overnight and continued today. Also started with pallor, headache and runny nose so Home tested for Covid and is positive this morning
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-07-31
    Survey response — days 1–6 daily, dose 2, under 3
    MedDRA: Body temperature increased, SARS-CoV-2 test positive — Feeling: Fair · Irritability/crying · Be unable to do your normal daily activities
    Free text: Did have continued fever yesterday afternoon post + Covid rapid antigen, but no true fever overnight or today thus far. TempHovering around 100 today.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-08-01
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Irritability/crying · Be unable to do your normal daily activities
    Under 3 check-in
  19. 2022-08-02
    Survey response — days 1–6 daily, dose 2, under 3
    MedDRA: COVID-19, Patient isolation — Feeling: Good · Be unable to do your normal daily activities
    Free text: Still isolating with Covid infection, but no symptoms remain
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-08-03
    Survey response — day 7, dose 2, under 3
    MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities
    Free text: Day 5 of Covid infection, no symptoms, back to baseline
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-08-10
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2022-08-17
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-08-24
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  24. 2022-08-31
    Survey response — day 35, dose 2, under 3
    MedDRA: Hyperacusis, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Increased sensitivity to sound, confirmed by pediatrician likely just normal developmental change
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-08-31
    Report sent to call center — day 35, dose 2, under 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  26. 2022-09-01
  27. 2022-09-07
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  28. 2022-10-26
    Survey response — 3 months, dose 2, under 3
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Just a cold
    MedDRA releases: 2024-11 · check-in free text available
  29. 2023-01-25
    Survey response — 6 months, dose 2, under 3
    MedDRA: Gastroenteritis viral — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  30. 2023-01-25
    Report sent to call center — 6 months, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  31. 2023-01-26
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  32. 2023-01-26
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12022-06-23Moderna No
22022-07-27Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2022-08-31 Successful
2023-01-26
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2023-01-25 Successful
2023-01-26
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-06-25

Systemic reaction (other): mild red rash to inner thigh of leg with injection yesterday afternoon, but resolved by evening

2022-06-27

Systemic reaction (other): Only mentioning 99.6 temp bc she felt feverish and seemed fussy, but no true fever. Note appears to be teething with 2 year molars as well

Release 12 (Under 3) — days 1–6 daily, dose 2, under 3

2022-07-28

Systemic reaction (other): Note leg pain was yesterday several hours after the shot, improved with ibuprofen. No complaints so far today

2022-07-30

Systemic reaction (other): Fever overnight and continued today. Also started with pallor, headache and runny nose so Home tested for Covid and is positive this morning

2022-07-31

Systemic reaction (other): Did have continued fever yesterday afternoon post + Covid rapid antigen, but no true fever overnight or today thus far. TempHovering around 100 today.

2022-08-02

Systemic reaction (other): Still isolating with Covid infection, but no symptoms remain

Release 12 (Under 3) — day 7, dose 2, under 3

2022-08-03

Systemic reaction (other): Day 5 of Covid infection, no symptoms, back to baseline

Release 12 (Under 3) — day 35, dose 2, under 3

2022-08-31

Symptoms: Increased sensitivity to sound, confirmed by pediatrician likely just normal developmental change

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-10-26

Symptoms: Just a cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGastroenteritis viral · · ✓
SDHyperacusis · · ✓
SDNasopharyngitis · · ✓
SDOffice visit · · ✓
SROBody temperature increased · · ✓
SROCOVID-19 · · ✓
SROHeadache · · ✓
SROIrritability · · ✓
SROPain in extremity · · ✓
SROPallor · · ✓
SROPatient isolation · · ✓
SROPyrexia · · ✓
SRORash · · ✓
SRORash erythematous · · ✓
SRORhinorrhoea · · ✓
SROSARS-CoV-2 test positive · · ✓
SROSelf-medication · · ✓
SROTeething · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release